Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - o+aung
32
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Combating Opioid-Induced Respiratory Depression Using Setmelanotide
The opioid crisis is a serious public health crisis in the United States. Mortality from opioid overdose increased by roughly ten times from 1999 to 2021. The primary cause of death is due to opioid-induced respiratory depression (OIRD). Currently, Naloxone and Nalmefene are actively used to reverse OIRD in emergency settings and by first responders....
Published: 7/30/2024
|
Inventor(s):
Vsevolod Polotsky
,
David Mendelowitz
,
O Aung
,
Mateus Ramos Amorim
,
Joan Escobar
Keywords(s):
Category(s):
Technology Classifications > Therapeutics > Small Molecules
,
Technology Classifications > Therapeutics > Repurposed Drugs
Microbial Markers for Autism
[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline 20 August 2021] We are inviting expressions of interest (EoI) for commercializing “Microbial Markers for Autism” technology. The innovation is developed by Professor Siew Chien Ng, Professor of the Department of Medicine and Therapeutics of The Chinese...
Published: 12/9/2021
|
Inventor(s):
Siew Chien NG
,
Ka Leung Francis CHAN
,
Zhilu XU
Keywords(s):
Category(s):
Diagnostics
Prediction of Colorectal Adenoma Recurrence
[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline 2 July 2021] We are inviting expressions of interest (EoI) for commercializing “Prediction of Colorectal Adenoma Recurrence” technology. The innovation is developed by Professor Siew Chien Ng, Professor of the Department of Medicine and Therapeutics of...
Published: 11/24/2021
|
Inventor(s):
Siew Chien NG
,
Ka Leung Francis CHAN
,
Qiaoyi Liang
Keywords(s):
Category(s):
Diagnostics
A Synbiotic Composition for Immunity
[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 25 September 2020] We are inviting expressions of interest (EoI) for commercializing “A Synbiotic Compsotion for Immunity” technology. The innovation is developed by Professor Siew Chien Ng, Professor of the Department of Medicine and Therapeutics of...
Published: 12/7/2022
|
Inventor(s):
Siew Chien NG
,
Ka Leung Francis CHAN
,
Zhilu XU
,
Wing Yan TANG
,
Qiaoyi Liang
Keywords(s):
Category(s):
Therapeutics
Methods relating to optimising and personalising microbial therapy
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 9 July 2020]We are inviting expressions of interest (EoI) for commercializing ““Methods relating to optimising and personalising microbial therapy” technology. The innovation is developed by Professor Ng Siew Chien, Professor of Department of Medicine...
Published: 12/9/2021
|
Inventor(s):
Siew Chien NG
,
Ka Leung Francis CHAN
Keywords(s):
Category(s):
Therapeutics
Fecal virome and therapeutic efficacy of fecal microbiota transplantation
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 9 July 2020]We are inviting expressions of interest (EoI) for commercializing ““Fecal virome and therapeutic efficacy of fecal microbiota transplantation” technology. The innovation is developed by Professor Ng Siew Chien, Professor of Department...
Published: 7/4/2022
|
Inventor(s):
Siew Chien NG
,
Tao ZUO
Keywords(s):
Category(s):
Therapeutics
Fecal fungome and therapeutic efficacy of fecal microbiota transplantation
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 9 July 2020]We are inviting expressions of interest (EoI) for commercializing “Fecal fungome and therapeutic efficacy of fecal microbiota transplantation” technology. The innovation is developed by Professor Ng Siew Chien, Professor of Department of Medicine...
Published: 8/9/2023
|
Inventor(s):
Siew Chien NG
,
Tao ZUO
,
Ka Leung CHAN
Keywords(s):
Category(s):
Therapeutics
2016-255 Method to Enrich for Cells Transduced with Chimeric Antigen Receptors for Gene Therapy (2016-051 rolled in)
Method to Enrich for Cells Transduced with Chimeric Antigen ReceptorsSUMMARYResearchers at UCLA have developed a method to expand chimeric antigen receptor-transduced T cells for use in immunotherapies.BACKGROUNDChimeric Antigen Receptors (CAR) T cells are promising therapeutics for the treatment of cancer and are also being considered for the treatment...
Published: 2/14/2024
|
Inventor(s):
Otto Yang
,
Jerome Zack
,
Scott Kitchen
,
Ayub Ali
,
Hwee Ng
,
Irvin S.Y. Chen
Keywords(s):
Oncology Immunotherapy
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Therapeutics > Oncology > Oncology Immunotherapy
Green diesel production from hydrotreating of soybean oil over supported bimetallic carbide catalysts
Currently, there are two types of hydroprocessing catalysts available for converting vegetable oils to diesel range hydrocarbons; supported noble metal catalysts (Pd or Pt) and sulfide bimetallic catalysts (usually Mo- or W-based sulfide promoted with Ni or Co). Disadvantages arise however using these catalysts, as their limited availability and...
Published: 2/7/2022
|
Inventor(s):
Huali Wang
,
Ka Yuen Simon Ng
,
Steven Salley
Keywords(s):
Category(s):
Advanced Manufacturing
,
Biofuels
,
Transportation
Thiadiazine Kinase Inhibitors
Thank you for your interest in this technology. Please see our technology brief here: https://app.in-part.com/articles/Mk10MZPK7vJj
Published: 7/1/2019
|
Inventor(s):
Robert Devita
,
Andrew Stewart
,
Avner Schlessinger
,
Kunal Kumar
,
Peter Ung
,
Hui Wang
,
Hailing Li
Keywords(s):
Category(s):
Therapeutic
1
2
3
4